SIMR is an innovation-oriented biopharmaceutical company dedicated to the discovery and development of new drugs for pain, inflammation and central nervous system related diseases. Since its establishment in 2014, the company has established a research and development platform of more than 3,000 square meters, with comprehensive drug development capabilities such as compound screening, CMC research, preclinical evaluation, and clinical development.
Company Details
- Employees
- 22
- Founded
- -
- Address
- 半夏路100号26号楼, 赛默罗simr,china
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://simrbio.com/en
- HQ
- Shanghai
Shanghai Simr Biotech Co.,ltd Questions
Shanghai Simr Biotech Co.,Ltd's website is http://simrbio.com/en
Shanghai Simr Biotech Co.,Ltd's LinkedIn profile is https://cn.linkedin.com/company/simrbiotechnology
Shanghai Simr Biotech Co.,Ltd has
22 employees.
View email and phone details for 22
employees at Shanghai Simr Biotech Co.,Ltd.
Shanghai Simr Biotech Co.,Ltd's industry is
Pharmaceutical Manufacturing
Shanghai Simr Biotech Co.,Ltd's top competitors are
Brunel,
Xiling Lab,
Astrazeneca,
Lp Pharmaceuticals, Inc.,
Beigene,
Johnson & Johnson,
Ovelle,
Wuxi Apptec,
Cipa Lab,
Novo Nordisk.
Shanghai Simr Biotech Co.,Ltd's categories are Pharmaceutical Manufacturing
Shanghai Simr Biotech Co.,Ltd's founding year is 2014
